CUCD-907—D3
- 价格： ￥99/瓶
- 发布日期： 2019-04-01
- 更新日期： 2025-02-28
产品详请
| 产地 |
加拿大
|
| 品牌 |
进口
|
| 货号 |
03-834512
|
| 英文名称 |
CUDC-907-d3
|
| 包装规格 |
1mg，10mg
|
| 纯度 |
98%
|
| CAS编号 |
|
| 别名 |
N-Hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-5-pyrimidinecarboxamide-d3; N-Hydroxy-2-[[[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl](methyl)amino]pyrimidine-5-carboxamide-d3;
|
| 分子式 |
C23H21D3N8O4S
|
货号：03-834512
中文名称：CUCD-907—D3
英文名称：Cumene Hydroperoxide (80%, Technical grade)
CAS号：
重量：1mg
重量：10mg
分子式：C23H21D3N8O4S
别名：N-Hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-5-pyrimidinecarboxamide-d3; N-Hydroxy-2-[[[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl](methyl)amino]pyrimidine-5-carboxamide-d3;
应用介绍：Labelled CUDC-907 is a dual PI3K and HDAC inhibitor. Studies have shown CUDC-907 is able to enhance antitumor activity when combined with standard of care agents in multiple myeloma and B cell lymphoma xenograft models.
